These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251 [TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470 [TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma. Ritz O; Guiter C; Castellano F; Dorsch K; Melzner J; Jais JP; Dubois G; Gaulard P; Möller P; Leroy K Blood; 2009 Aug; 114(6):1236-42. PubMed ID: 19423726 [TBL] [Abstract][Full Text] [Related]
6. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma. Miloudi H; Leroy K; Jardin F; Sola B Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729 [TBL] [Abstract][Full Text] [Related]
8. The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6. Hsu YA; Huang CC; Kung YJ; Lin HJ; Chang CY; Lee KR; Wan L Cancer Lett; 2016 Jun; 375(2):303-312. PubMed ID: 26945968 [TBL] [Abstract][Full Text] [Related]
10. Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL. Chu Y; Awasthi A; Lee S; Edani D; Yin C; Hochberg J; Shah T; Chung TH; Ayello J; van de Ven C; Klein C; Lee D; Cairo MS Oncotarget; 2020 Aug; 11(32):3035-3047. PubMed ID: 32850008 [TBL] [Abstract][Full Text] [Related]
11. Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas. Drexler HG; Ehrentraut S; Nagel S; Eberth S; MacLeod RA Leuk Res; 2015 Jan; 39(1):18-29. PubMed ID: 25480038 [TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting. Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315 [TBL] [Abstract][Full Text] [Related]
14. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234 [TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453 [TBL] [Abstract][Full Text] [Related]
17. [A case of primary mediastinal (Thymic) B-cell lymphoma successfully treated with the DA-EPOCH-R Regimen]. Higashide Y; Hayashi T; Hirayama D; Wagatsuma K; Aoki Y; Maruyama Y; Ikeda H; Ishida T; Shinomura Y Gan To Kagaku Ryoho; 2015 Jan; 42(1):119-22. PubMed ID: 25596693 [TBL] [Abstract][Full Text] [Related]
18. Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy. Goldschmidt N; Kleinstern G; Orevi M; Paltiel O; Ben-Yehuda D; Gural A; Libster D; Lavie D; Gatt ME Cancer Chemother Pharmacol; 2016 May; 77(5):1053-60. PubMed ID: 27056383 [TBL] [Abstract][Full Text] [Related]
19. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. Chen BJ; Ruminy P; Roth CG; Bisig B; Mankel B; Steinhilber J; Bohers E; Jardin F; Fend F; Swerdlow SH; Copie-Bergman C; de Leval L; Quintanilla-Martinez L Am J Surg Pathol; 2019 Jan; 43(1):110-120. PubMed ID: 30211726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]